Thomson X, a wholly-owned subsidiary of Thomson Medical Group, has inked a strategic partnership with Plano, a Singapore-based healthtech startup.

The collaboration will leverage on the strengths of Thomson X and Plano to address and manage myopia through technological solutions, which Plano specialises in.

Myopia is said to be growing into one of the biggest public health challenges in the world, affecting 2.6 billion globally.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook